Company / Shareholders' Equity
PURE BIOSCIENCE, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$5.1M
FY2025
5-year range
-$5.1M / $3.9M
FY2021-FY2025
Trend
-78.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PURE BIOSCIENCE, INC. reports negative total equity of -$5M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$5M in FY2025.
Declined from $272,000 to -$5M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PURE BIOSCIENCE, INC.'s shareholders' equity has declined for 3 consecutive years.
- In FY2025, shareholders' equity decreased 78.6% year-over-year.
- Peak shareholders' equity was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.1M | -78.6% |
| FY2024 | -$2.9M | -1152.9% |
| FY2023 | $272.0K | -93.0% |
| FY2022 | $3.9M | +17.3% |
| FY2021 | $3.3M | -30.7% |
| FY2020 | $4.8M | +304.3% |
| FY2019 | $1.2M | -7.1% |
| FY2018 | $1.3M | -0.7% |
| FY2017 | $1.3M | -74.3% |
| FY2016 | $5.0M | +110.8% |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026